期刊文献+

小鼠微小病毒Q-PCR检测方法在病毒去除工艺验证中的应用

Application of Q-PCR method for murine minute virus in validation of procedure for virus clearance
原文传递
导出
摘要 目的将小鼠微小病毒(murine minute virus,MVM)Q-PCR检测方法应用于病毒去除工艺验证中。方法使用MVM Q-PCR法和细胞病变法同时检测10倍系列稀释后的MVM,建立核酸拷贝数与病毒滴度之间的函数关系,并应用于纳米膜过滤和层析病毒去除工艺验证中。结果核酸拷贝数与病毒滴度间呈线性关系,R^2可达0.9863。应用于纳米膜过滤去除工艺验证,两种方法检测结果具有一致性;应用于层析去除工艺验证,两种方法在亲和层析、阴离子柱层析、阴离子Q膜层析工艺中结果具有一致性,但在具有灭活病毒的疏水层析中,结果不一致。结论在病毒去除工艺验证中,MVM Q-PCR法可作为现有细胞病变法的补充。 Objective To apply the Q-PCR method for murine minute virus(MVM)to the validation of procedure for virus clearance.Methods The 10-fold serially diluted MVM was determined by MVM Q-PCR and CPE method simultaneously,based on which a functional relationship between nucleic acid copy number and virus titer was established and applied to the validation of procedure for virus clearance by nanomembrane filtration and chromatography.Results The copy number of nucleic acid was linearly correlated to the virus titer,with a R^2 value of 0.9863.The determination results by MVM Q-PCR and CPE method were in agreement in validation of virus clearance by nanomembrane filtration.However,in validation of various chromatographic procedures,the determination results by the two methods were in agreement in affinity chromatography,anion exchange chromatography and anion Q membrane chromatography,while were inconsistent in hydrophobic chromatography.Conclusion MVM Q-PCR method may be used as a supplement of CPE method for validation of procedure for virus clearance.
作者 付瑞 王淑菁 秦晓 王莎莎 王吉 李晓波 李威 岳秉飞 FU Rui;WANG Shu-jing;QIN Xiao;WANG Sha-sha;WANG Ji;LI Xiao-bo;LI Wei;YUE Bing-fei(National Institutes for Food and Drug Control,Beijing 102629,China)
出处 《中国生物制品学杂志》 CAS CSCD 2020年第5期558-562,共5页 Chinese Journal of Biologicals
基金 国家重点研发计划(2017YFD0501606)“疫病易感型小型猪筛选及种群建立”。
关键词 微小病毒 Q-PCR 病毒去除 细胞病变法 Murine minute virus(MVM) Mouse Q-PCR Virus clearance CPE method
  • 相关文献

参考文献5

二级参考文献36

  • 1殷华平,郭万柱,徐志文,罗燕.猪细小病毒(PPV)SC1株的分离鉴定[J].黑龙江畜牧兽医,2006(7):63-65. 被引量:20
  • 2赵灵燕,徐辉,陈伟杰,王勇,倪柏锋,周彩琴,吴赟竑.猪细小病毒病PCR检测方法的建立及应用[J].浙江畜牧兽医,2006,31(5):5-6. 被引量:1
  • 3药品审评中心.生物组织提取制品和真核细胞表达制品的病毒安全性评价技术审评一般原则[S].2005.
  • 4Miesegaes G, Lute S, Brorson K. Analysis of viral clearance utail operations for monoclonal antibodies [J]. Biotechnol Bioeng, 2010, 106 (2): 238-246.
  • 5Brorson K, Brown J, Hamilton E, et al. Identification of protein A media performanee attributes that c;an be monitored as surrogates for retrovirus clearance during extended re-use [J]. J Chromatogr A, 2003, 989 (1): 155-163.
  • 6Tharakan J, Highsmith F, Clark D, et al. Physical and biochemical characterization of five commercial resins for immunoaffinity purification of factor IX [J]. J Chromatogr, 1992, 595 (1-2): 103- 111.
  • 7Bill E, Lutz U, Karlsson BM, et al. Optimization of protein G chromatography fots biopharmaceutical motloclonal antibodies [J ]. J Mot Recognit, 1995, 8 (1-2) : 90-94.
  • 8Godfrey MA, Kwasowski P, Clift R et ol. Assessment of the suit- ability of commercially available SpA affinity solid phases for the purification of murine monoclonal atttlbodies at process scale [J]. J Immunol Methods, 1993, 160 ( 1 ): 97-105,.
  • 9I Jiang C, Liu J, Rubaeha M, etal. A mechanistic study of Protein A chromatography resin lifetime [J]. J Ghromatogr A, 2009, 1216 (31) : 5849-5855.
  • 10Lute S, Norling L, Hanson M, et al. Robustness of virus removal by protein A chromatography is independent of media lifetime [ J ]. J Chromatogr A, 2008, 1205 (1-~)j 17-25.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部